REGN
Regeneron Pharmaceuticals, Inc.
Biotechnology company focused on developing and commercializing medicines for serious diseases.
CUSIP: 75886F107HealthcareUS4 holders
Total Value
$1.07B
Total Shares
1.69M
Net Share Change
+131.0K
Activity
3 buying
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$985.46M1.55M sharesUnchanged
